- September 2014
Discussing how healthcare systems can meet the needs of cancer survivors.
- July/August 2014
Sophie Postel-Vinay on new recommendations for phase 1 trials.
- June 2014
Hans Clevers on important research into stem cells in normal gut tissue.
- May 2014
Carolyn Taylor and Paul McGale find evidence to clarify guidelines for radiotherapy after mastectomy.
- April 2014
Richard Sullivan and Ajay Aggarwal on how physicians can tackle the issue of affordability in cancer care.
- March 2014
The 1st EORTC Cancer Survivorship Summit addressed the practical problems faced by cancer patients.
- February 2014
Charles Swanton on a study that maps genetic changes in cancers over time.
- January 2014
Presidents of various cancer societies make predictions for the coming year.
- December 2013
Precision diagnostics have great potential, but changes are needed to make them more available.
- November 2013
Highlights of the European Cancer Congress - cancer society presidents give their view.
- October 2013
Richard Schilsky on the changes needed as personalised medicine enters the clinic.
- September 2013
A new advance in immunotherapy is discussed by Jean-Charles Soria and Caroline Robert.
EJC News Focus – November 2013
Highlights of European Cancer Congress
"Astonishing" results with immunotherapy in a range of hard to treat cancers were the highlight of the Congress (27 September – 1st October, 2013) for Martine Piccart (ESMO). For Vincenzo Valentini (ESTRO), it was the new perception that that local treatment with radiation therapy could have an impact on systemic disease. Graeme Poston (ESSO) picked out the training of young surgical oncologists, which may now last only 6,000 hours, compared with up to 40,000 hours for previous generations of surgeons. How can the profession ensure that they are safe?
In this month's EJC News Focus, Helen Saul meets the Presidents of various cancer societies, including Moshe Oren (EACR), Birgitte Grube (EONS) and Cornelis van de Velde (ECCO), and asks for their take-home messages from the European Cancer Congress.